SouFun Holdings Ltd. (NYSE:SFUN) shares decreased -3.34% in last trading session and ended the day at $5.79. SFUN Gross Margin is 37.10% and its has a return on assets of -0.80%. SouFun Holdings Ltd. (NYSE:SFUN) quarterly performance is -19.02%.
SouFun Holdings Ltd (NYSE:SFUN) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued to investors on Wednesday, ARN reports.
Omnicell, Inc. (NASDAQ:OMCL) ended the last trading day at $27.95. Company weekly volatility is calculated as 3.31% and price to cash ratio as 12.05. Omnicell, Inc. (NASDAQ:OMCL) showed a weekly performance of 9.91%.
Omnicell, Inc. (NASDAQ:OMCL) announced general availability of its latest medication adherence solution, the SureMed™ by Omnicell® Guided Packing software. This cloud-based software is designed to increase pharmacists’ accuracy in filling SureMed multiple medication blister cards, which can improve medication adherence for patients on complex medication regimens. At launch, the software will interface with QS1, one of the most widely used pharmacy information systems (PIS), and is planned to integrate with additional systems later this year.
On 01 April, Symantec Corporation (NASDAQ:SYMC) shares advanced 0.16% and was closed at $18.41. SYMC EPS growth in last 5 year was 7.70%. Symantec Corporation (NASDAQ:SYMC) year to date (YTD) performance is 9.72%.
On 21 March, Symantec Corporation (NASDAQ:SYMC) fixed three high-risk security vulnerabilities in Symantec Endpoint Protection last week, which serves as a reminder: Security software needs to be regularly patched, too.
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) shares moved up 4.52% in last trading session and ended the day at $12.49. LXRX has a return on assets of -1.00%. Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) quarterly performance is -6.51%.
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) announced that it has submitted a New Drug Application to the U.S. Food and Drug Administration seeking approval for the marketing and sale of telotristat etiprate, an oral drug for the treatment of carcinoid syndrome. The FDA has a 60-day filing review period to determine whether the NDA is complete and acceptable for filing. Lexicon has requested a Priority Review by the FDA as part of the NDA filing.
CMS Energy Corp. (NYSE:CMS) caters to the Utilities space. It has a net profit margin of 8.10% and weekly performance is 2.47%. On the last day of trading company shares ended up at $42.71. CMS Energy Corp. (NYSE:CMS) distance from 50-day simple moving average (SMA50) is 7.39%.
CMS Energy Corp. (NYSE:CMS) announced that its subsidiary, Consumers Energy, will close down its seven oldest coal plants called the “Classic Seven” by April 15. The coal plants, which collectively generate up to 1,000 megawatts (MW) of electricity, had been serving communities in Michigan for more than 60 years.
Leave a Reply